Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,328 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Progress and promise for the MDMA drug development program.
Feduccia AA, Holland J, Mithoefer MC. Feduccia AA, et al. Among authors: holland j. Psychopharmacology (Berl). 2018 Feb;235(2):561-571. doi: 10.1007/s00213-017-4779-2. Epub 2017 Nov 20. Psychopharmacology (Berl). 2018. PMID: 29152674 Review.
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
Mithoefer MC, Mithoefer AT, Feduccia AA, Jerome L, Wagner M, Wymer J, Holland J, Hamilton S, Yazar-Klosinski B, Emerson A, Doblin R. Mithoefer MC, et al. Among authors: holland j. Lancet Psychiatry. 2018 Jun;5(6):486-497. doi: 10.1016/S2215-0366(18)30135-4. Epub 2018 May 1. Lancet Psychiatry. 2018. PMID: 29728331 Clinical Trial.
MDMA for the Treatment of Negative Symptoms in Schizophrenia.
Arnovitz MD, Spitzberg AJ, Davani AJ, Vadhan NP, Holland J, Kane JM, Michaels TI. Arnovitz MD, et al. Among authors: holland j. J Clin Med. 2022 Jun 7;11(12):3255. doi: 10.3390/jcm11123255. J Clin Med. 2022. PMID: 35743326 Review.
2,328 results